New insights into ischemic heart disease in women

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 8, 2007, Pages 585-594

  Bellasi, Antonio ^a,b   Raggi, Paolo ^a   Merz, C Noel Bairey ^c,d   Shaw, Leslee J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY ATHEROSCLEROSIS; ECHOGRAPHY; ENDOTHELIUM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM; FEMALE; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 35248861264     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.8.585     Document Type: Review

References (57)

1. Thom T, Haase N. Rosamond W. et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85-e151.
2. Shaw LJ, Bairey Merz CN, Pepline CJ, et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006; 47:54-520.
3. Bairey Merz N, Bonow RO, Sopko G, et al. Women's Ischemic Syndrome, Evaluation: current status and future research directions: report of the National Heart Lung and Blood institute workshop: October 2-4, 2002: executive summary. Circulation 2004; 109:805-807.
4. Mosca L. Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109:672-693.
5. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111:383-390.
6. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999; 34:1348-1359.
7. Mosca L, Grundy SM, Judelson D, et al. AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. J Am Coll Cardiol 1999; 33:1751-1755.
8. Vaccarino V. Angina and cardiac care: are there gender differences, and if so, why? Circulation 2006; 113:467-469.
9. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes Ilb investigators. N Engl J Med 1999; 341:226-232.
10. Daly C, Clemens F, Lopez Sendon JL, et al. Gender differences in the management and clinical outcome of stable angina. Circulation 2006; 113:490-498.
11. Shaw LJ, Lewis JF, Hlatky MA, et al. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart Lung and Blood Institute workshop: October 2-4, 2002: Section 5: gender-related risk factors for ischemic heart disease. Circulation 2004; 109:e56-58.
12. Merz NB, Johnson BD, Kelsey PSF, et al. Diagnostic, prognostic, and cost assessment of coronary artery disease in women. Am J Manag Care 2001; 7:959-965.
13. Pepine CJ, Balaban RS, Bonow RO, et al. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart Lung and Blood Institute workshop: October 2-4, 2002: section 1: diagnosis of stable ischemia and ischemic heart disease. Circulation 2004, 109:e44-e46.
14. Tuzcu EM, Berkalp B, De Franco AC, et al. The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. J Am Coll Cardiol 1996; 27:832-838.
15. Chaitman BR, Bourassa MG, Davis K, et al. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation 1981; 64:360-367.
16. Enriquez-Sarano M, Klodas E, Garratt KN, Bailey KR, Tajik AJ, Holmes DR Jr. Secular trends in coronary atherosclerosis - analysis in patients with valvular regurgitation. N Engl J Med 1996; 335:316-322.
17. Merz CN, Kelsey SF, Pepine CJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) Study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33:1453-1461.
18. Quyyumi AA. Women and ischemic heart disease: pathophysiologic implications from the Women's Ischemia Syndrome Evaluation (WISE) study and future research steps. J Am Coll Cardiol 2006; 47:S66-S71.
19. Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006; 47:S21-S29.
20. Dodge JT Jr. Brown BG, Bolson EL, Dodge HT. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation 1992; 86:232-246.
21. Sheifer SE, Canos MR, Weinfurt KP, et al. Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J 2000; 139:649-653.
22. Kornowski R, Lansky AJ, Mintz GS, et al. Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol 1997; 79:1601-1605.
23. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998, 97:2110-2116.
24. Arbustini E, Dal Bello B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82:269-272.
25. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23:168-175.
26. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108:2054-2059.
27. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40:505-510.
28. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106:653-658.
29. Detrano R, Froelicher VF. Exercise testing: uses and limitations considering recent studies. Prog Cardiovasc Dis 1988; 31:173-204.
30. Lewis JF, McGorray SP, Pepine CJ. Assessment of women with suspected myocardial ischemia: review of findings of the Women's Ischemia Syndrome Evaluation (WISE) Study. Curr Womens Health Rep 2002; 2:110-114.
31. Milner KA, Funk M, Arnold A, Vaccarino V. Typical symptoms are predictive of acute coronary syndromes in women. Am Heart J 2002; 143:283-288.
32. McSweeney JC, Cody M. O'Sullivan P, Elberson K, Moser DK, Garvin BJ. Women's early warning symptoms of acute myocardial infarction. Circulation 2003; 108:2619-2623.
33. Rosengren A. Wallentin L. Gitt KA, Behar S, Battler A, Hasdal D. Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J 2004, 25:663-670.
34. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290:891-897.
35. Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104:1108-1113.
36. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3:213-219.
37. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002; 162:1737-1745.
38. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265:627-631.
39. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004; 43:1663-1669.
40. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996, 16:1509-1515.
41. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997; 145:614-619.
42. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-733.
43. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. Circulation 2004; 109:706-713.
44. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement. Study (HERS) Research Group. JAMA 1998; 280:605-613.
45. Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Cardiovascular outcomes during 6-8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288:49-57.
46. Writing Group for the Womens Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. Principal results from the Women's health Initiative Randomized Controlled Trial. JAMA 2002; 288:321-333.
47. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 2004; 28:1018-1025.
48. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms foe the assessment of global cardiovascular risk in women. The Reynolds Risk Score. JAMA 2007; 297:611-619.
49. Raggi P, Shaw LJ, Berman DS, Callister TQ. Gender-based differences in the prognostic value of coronary calcifitation, J Womens Health (Larchmt) 2004; 13:273-283.
50. Mieres JH, Shaw LJ, Arai A. et al, for the Cardiovascular Imaging Committee. American Heart Association-Cardiac Imaging Committee Consensus Statement: the role of cardiac imaging in the clinical evaluation of women with known or suspected coronary artery disease. Circulation 2005; 111:682-696.
51. Handberg E, Johnson BD, Arant CB, et al. Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006; 47:S44-S49.
52. Shaw LJ, Olson MB, Kip K, et al. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006; 47:S36-S43.
53. Gierach GL, Johnson BD, Bairey Merz CN, et al. Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006; 47:S50-S58.
54. Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: longterm mortality in 4,234 women and 6,898 men. Eur Heart J 2005; 26:447-456.
55. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 2007; 49:227-237.
56. Mieres JH, Shaw LJ, Handel RC, et al. Consensus statement: American Society of Nuclear Cardiology: task force on women and coronary artery disease - the role of myocardial perfusion imaging in the clinical evaluatiom of coronary artery disease in women. J Nucl Cardiol 2003; 10:95-110.
57. Panting JR, Gatehouse PD, Yang GZ et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346:1948-1953.